First Citizens Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-362
| Closed | -$258K | – | 534 |
|
|
2024
Q4 | $258K | Buy |
362
+85
| +31% | +$60.5K | ﹤0.01% | 413 |
|
|
2024
Q3 | $291K | Sell |
277
-12
| -4% | -$12.6K | 0.01% | 377 |
|
|
2024
Q2 | $304K | Sell |
289
-6
| -2% | -$6.31K | 0.01% | 369 |
|
|
2024
Q1 | $284K | Buy |
+295
| New | +$284K | 0.01% | 381 |
|
|
2023
Q1 | – | Sell |
-333
| Closed | -$240K | – | 338 |
|
|
2022
Q4 | $240K | Buy |
+333
| New | +$240K | 0.01% | 290 |
|
|
2020
Q4 | – | Sell |
-2,273
| Closed | -$1.27M | – | 403 |
|
|
2020
Q3 | $1.27M | Buy |
2,273
+42
| +2% | +$23.5K | 0.09% | 167 |
|
|
2020
Q2 | $1.39M | Buy |
+2,231
| New | +$1.39M | 0.12% | 155 |
|
|
2016
Q1 | – | Sell |
-4,455
| Closed | -$2.42M | – | 448 |
|
|
2015
Q4 | $2.42M | Sell |
4,455
-5
| -0.1% | -$2.71K | 0.18% | 110 |
|
|
2015
Q3 | $2.08M | Sell |
4,460
-150
| -3% | -$69.8K | 0.15% | 123 |
|
|
2015
Q2 | $2.35M | Sell |
4,610
-150
| -3% | -$76.5K | 0.16% | 122 |
|
|
2015
Q1 | $2.15M | Sell |
4,760
-150
| -3% | -$67.7K | 0.15% | 125 |
|
|
2014
Q4 | $2.01M | Sell |
4,910
-198
| -4% | -$81.2K | 0.15% | 117 |
|
|
2014
Q3 | $1.84M | Buy |
5,108
+1,948
| +62% | +$702K | 0.15% | 115 |
|
|
2014
Q2 | $893K | Buy |
3,160
+190
| +6% | +$53.7K | 0.08% | 167 |
|
|
2014
Q1 | $892K | Sell |
2,970
-3,464
| -54% | -$1.04M | 0.08% | 162 |
|
|
2013
Q4 | $1.77M | Sell |
6,434
-5,771
| -47% | -$1.59M | 0.16% | 116 |
|
|
2013
Q3 | $3.82M | Buy |
12,205
+5,089
| +72% | +$1.59M | 0.15% | 160 |
|
|
2013
Q2 | $1.6M | Buy |
+7,116
| New | +$1.6M | 0.07% | 271 |
|